Skip to main content
SpringerLink
Log in

Reply to “New IFSO/ASMBS Indications for Metabolic and Bariatric Surgery? Yes, After Failure of Best Nonsurgical Therapy”

  • Letter to Editor/LED Reply
  • Published:
Obesity Surgery Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Gastrointestinal surgery for severe obesity. NIH Consens Dev Conf Consens Statement 1991;9(1):1–20.

  2. Eisenberg D, Shikora SA, Aarts E, et al. 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): indications for metabolic and bariatric surgery. Obes Surg. 2023;33:3–14.

    Article  PubMed  Google Scholar 

  3. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384:989–1002.

    Article  CAS  PubMed  Google Scholar 

  4. Garvey WT, Batterham RL, Bhatta M, et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nat Med. 2022;28:2083–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387:205–16.

    Article  CAS  PubMed  Google Scholar 

  6. Valdez S, et al. Obes Surg. 2023.

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Stanford School of Medicine and VA Palo Alto Health Care System, 3801 Miranda Avenue, GS 112, Palo Alto, CA, 94304, USA

    Dan Eisenberg

  2. Department of Surgery, Center for Metabolic and Bariatric Surgery, Brigham and Women’s Hospital, and Harvard Medical School, Boston, MA, USA

    Scott A. Shikora

  3. Prisma Health, Department of Surgery, University of South Carolina School of Medicine, Greenville, SC, USA

    Shanu N. Kothari

Authors
  1. Dan Eisenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Scott A. Shikora
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shanu N. Kothari
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dan Eisenberg.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Eisenberg, D., Shikora, S.A. & Kothari, S.N. Reply to “New IFSO/ASMBS Indications for Metabolic and Bariatric Surgery? Yes, After Failure of Best Nonsurgical Therapy”. OBES SURG 33, 2594–2595 (2023). https://doi.org/10.1007/s11695-023-06667-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-023-06667-3

Search

Navigation